SE9302437L - N-Derivat av (fenyletyl-beta-ol)amin, ett förfarande för deras framställning och läkemedelskompositioner som innehåller desamma - Google Patents

N-Derivat av (fenyletyl-beta-ol)amin, ett förfarande för deras framställning och läkemedelskompositioner som innehåller desamma

Info

Publication number
SE9302437L
SE9302437L SE9302437A SE9302437A SE9302437L SE 9302437 L SE9302437 L SE 9302437L SE 9302437 A SE9302437 A SE 9302437A SE 9302437 A SE9302437 A SE 9302437A SE 9302437 L SE9302437 L SE 9302437L
Authority
SE
Sweden
Prior art keywords
phenylethyl
beta
preparation
same
amine
Prior art date
Application number
SE9302437A
Other languages
English (en)
Other versions
SE9302437D0 (sv
SE503805C2 (sv
Inventor
Serge Auvin
Pierre Braquet
Colette Broquet
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of SE9302437D0 publication Critical patent/SE9302437D0/sv
Publication of SE9302437L publication Critical patent/SE9302437L/sv
Publication of SE503805C2 publication Critical patent/SE503805C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE9302437A 1992-07-17 1993-07-16 N-Derivat av (fenyletyl-beta-ol)amin, ett förfarande för deras framställning och läkemedelskompositioner som innehåller desamma SE503805C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929215274A GB9215274D0 (en) 1992-07-17 1992-07-17 Derivatives of(phenylethyl-beta-ol)amine

Publications (3)

Publication Number Publication Date
SE9302437D0 SE9302437D0 (sv) 1993-07-16
SE9302437L true SE9302437L (sv) 1994-01-18
SE503805C2 SE503805C2 (sv) 1996-09-09

Family

ID=10718914

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9302437A SE503805C2 (sv) 1992-07-17 1993-07-16 N-Derivat av (fenyletyl-beta-ol)amin, ett förfarande för deras framställning och läkemedelskompositioner som innehåller desamma

Country Status (32)

Country Link
US (1) US5447942A (sv)
JP (1) JP3204811B2 (sv)
AT (1) AT403693B (sv)
AU (1) AU672791B2 (sv)
BE (1) BE1006429A3 (sv)
CA (1) CA2100381C (sv)
CH (1) CH687705A5 (sv)
DE (1) DE4323976C2 (sv)
DK (1) DK84793A (sv)
DZ (1) DZ1704A1 (sv)
ES (1) ES2067417B1 (sv)
FI (1) FI933235L (sv)
FR (2) FR2693653B1 (sv)
GB (2) GB9215274D0 (sv)
GR (1) GR1001565B (sv)
HK (1) HK52596A (sv)
HU (1) HUT64757A (sv)
IE (1) IE73266B1 (sv)
IN (1) IN183086B (sv)
LU (1) LU88383A1 (sv)
MA (1) MA22937A1 (sv)
MY (1) MY109395A (sv)
NL (1) NL9301241A (sv)
NO (1) NO302946B1 (sv)
NZ (1) NZ248041A (sv)
OA (1) OA09838A (sv)
PL (1) PL173783B1 (sv)
PT (1) PT101308B (sv)
RU (1) RU2060252C1 (sv)
SE (1) SE503805C2 (sv)
TN (1) TNSN93081A1 (sv)
ZA (1) ZA934667B (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2579756C (en) * 2004-06-19 2013-04-30 Human Biomolecular Research Institute Modulators of central nervous system neurotransmitters
WO2020148325A1 (en) 2019-01-15 2020-07-23 Phenex-Fxr Gmbh Neutral lxr modulators
GB202304652D0 (en) * 2023-03-29 2023-05-10 Atrogi Ab New compounds and medical uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3700692A (en) 1971-06-04 1972-10-24 Colgate Palmolive Co 1-(4{40 -hydroxy-3{40 -(hydroxy methyl)-phenyl)-1-hydroxy-2-aralkylaminoethanes
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
DE3513885A1 (de) * 1984-04-17 1985-10-17 Glaxo Group Ltd., London Phenethanolaminverbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3731198A1 (de) * 1987-02-07 1988-08-18 Bayer Ag 2-aminomethyltetrahydrofurane
EP0286242A3 (en) * 1987-03-12 1989-08-09 Glaxo Group Limited Ethanolamine derivates, processes for their preparation and pharmaceutical compositions containing them
GB2230525A (en) * 1989-04-14 1990-10-24 Glaxo Group Ltd 1-(Hydroxyphenyl)-2-aminoethanol derivatives
GB2230775A (en) * 1989-04-24 1990-10-31 Glaxo Group Ltd Phenethanolamine compounds
NZ235605A (en) * 1989-10-10 1992-12-23 Glaxo Group Ltd (r)-(-)-4-hydroxy-alpha 1 -(((6-(4-phenylbutoxy)hexyl)amino)methyl)-1,3-benzenedimethanol and pharmaceutical compositions

Also Published As

Publication number Publication date
GB2268742B (en) 1995-11-08
GB9215274D0 (en) 1992-09-02
HK52596A (en) 1996-04-03
LU88383A1 (fr) 1994-04-01
FI933235A7 (sv) 1994-01-18
CA2100381A1 (en) 1994-01-18
DK84793D0 (da) 1993-07-16
FI933235A0 (fi) 1993-07-16
GB9314718D0 (en) 1993-08-25
IN183086B (sv) 1999-09-04
PT101308B (pt) 1999-10-29
MA22937A1 (fr) 1994-04-01
SE9302437D0 (sv) 1993-07-16
ES2067417A1 (es) 1995-03-16
HUT64757A (en) 1994-02-28
PL173783B1 (pl) 1998-04-30
CA2100381C (en) 2004-09-21
JPH06157492A (ja) 1994-06-03
AU672791B2 (en) 1996-10-17
FR2693653B1 (fr) 1994-10-28
AT403693B (de) 1998-04-27
ATA142793A (de) 1997-09-15
FR2693723B1 (fr) 1994-10-28
DE4323976C2 (de) 2003-05-28
PT101308A (pt) 1994-05-31
FR2693723A1 (fr) 1994-01-21
FI933235L (fi) 1994-01-18
ES2067417B1 (es) 1995-11-16
NL9301241A (nl) 1994-02-16
GR1001565B (el) 1994-05-31
DK84793A (da) 1994-01-18
DE4323976A1 (de) 1994-01-20
DZ1704A1 (fr) 2002-02-17
NO932383L (no) 1994-01-18
NZ248041A (en) 1994-06-27
HU9302057D0 (en) 1993-10-28
PL299693A1 (en) 1994-03-21
BE1006429A3 (fr) 1994-08-23
MY109395A (en) 1997-01-31
IE73266B1 (en) 1997-05-21
CH687705A5 (fr) 1997-01-31
JP3204811B2 (ja) 2001-09-04
ZA934667B (en) 1994-01-25
US5447942A (en) 1995-09-05
AU4204293A (en) 1994-01-20
SE503805C2 (sv) 1996-09-09
NO932383D0 (no) 1993-06-29
RU2060252C1 (ru) 1996-05-20
NO302946B1 (no) 1998-05-11
FR2693653A1 (fr) 1994-01-21
TNSN93081A1 (fr) 1994-03-17
IE930472A1 (en) 1994-01-26
OA09838A (fr) 1994-08-15
GB2268742A (en) 1994-01-19

Similar Documents

Publication Publication Date Title
DE3873612D1 (de) Dithioacetal-verbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
MX9306831A (es) Nuevos compuestos heterociclicos.
DK0528337T3 (da) Thiazolylbenzofuranderivater, fremgangsmåde til fremstilling deraf og farmaceutiske præparater, der indeholder disse forbin
CA2160444A1 (en) Aroyl-piperdine derivatives
EP0970954A4 (en) 3-PIPERIDYL-4-OXOCHINAZOLINE DERIVATIVES AND MEDICAL COMPOSITIONS CONTAINING THEM
PT97993A (pt) Processo para a preparacao de derivados de amidas ciclicas e de composicoes farmaceuticas que os contem
IL151172A0 (en) Amine derivatives, their preparation and use as bax modulators
DK0842661T3 (da) Anvendelse af estrogenagonister og -antagonister til fremstilling af et lægemiddel til behandling af atherosclerose, uafhængigt af lipidsænkning
MX9202844A (es) 1-indolilalquil-4-( alcoxi-pirimidinil) piperazinas y composicion farmaceutica que las contiene.
CA2103590A1 (en) Benzamide derivative
BR9305164A (pt) Composto, formulação farmacêutica e processo para preparar um composto
EA200300044A1 (ru) Новые замещенные фталиды, способ их получения и содержащие их фармацевтические композиции
NO173444C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 4-(4'- fluorfenyl-)-tienopyridin-derivater
NO892295D0 (no) Fremgangsmaate for fremstilling av nye cefemforbindelser.
LV11689A (lv) 4-Ú(2-benzotiazolil)metilamino¾-alfa-Ú(3,4-difluorfenoksi)metil¾-1-piperidinetanols
EP0712398A1 (en) BENZOPYRANS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
SE9302437L (sv) N-Derivat av (fenyletyl-beta-ol)amin, ett förfarande för deras framställning och läkemedelskompositioner som innehåller desamma
HK95092A (en) 2-substituted n,n-di-trimethoxybenzoyl piperazines and pharmaceutical uses thereof
NO910904D0 (no) Fremgangsmaate for fremstilling av en substituert aminforbindelse.
DE69329184D1 (de) Alkylsubstituierte heterocyclische Verbindungen
DK0427518T3 (da) NMDA-blokerende forbindelser, farmaceutiske præparater, deres fremstilling og anvendelse
SE9203824L (sv) Bensofuranylimidazol-derivat, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande desamma
IL111404A (en) Pharmaceutical compositions for the enhancement ofmemory and cognition comprising 3-aryl-4-alkyl and 4,5-dialkyl-4H-1,2,4-triazoles and some such novel compounds
RU93046412A (ru) N-ПРОИЗВОДНЫЕ (ФЕНИЛЭТИЛ- β -ОЛ)АМИНА, СПОСОБ ЕГО ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ
IT1264695B1 (it) N-derivati di (feniletil-beta-ol)ammina, un procedimento per la loro preparazione e composizione farmaceutiche che li contengono

Legal Events

Date Code Title Description
NUG Patent has lapsed